Hepatitis B and C Virus Co-Infection and Their Association With Liver Disease in Persons With HIV in Nigeria

Emuobor Odeghe*, Ganiyat Oyeleke, Mayowa Odofin, Mary Duguru, Pantong Davwar, David Nyam, Olufunmilayo Lesi, Edith Okeke, Hameed Adelabu, Oluwakemi Odukoya, Alani Akanmu, Wasiu Adeyemo, Fatimah Abdulkareem, Godwin Imade, Brian Joyce, Imran Khan, Ariel Chandler, Atiene Sagay, Robert Murphy, Lifang HouClaudia Hawkins

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Background: The burden of chronic viral hepatitis among people living with human immunodeficiency virus (PLWH) and its association with liver disease in Nigeria has been seldom explored. Our objective was to compare characteristics in PLWH with and without significant liver fibrosis/cirrhosis, examining its association with viral hepatitis and other risk factors. Methods: Cross-sectional study among PLWH with and without significant fibrosis/cirrhosis (transient elastography ≥ 9.3 kPa) between July 2018 and August 2022. Data were compared between participant groups and logistic regression used to determine association between chronic viral hepatitis and significant fibrosis/cirrhosis. Results: Five hundred and thirty-seven participants (34.3% male), median age 46 years, 22.2% with significant fibrosis/cirrhosis were analyzed. Seroprevalence of hepatitis B virus (HBV) was 11.2% and hepatitis C virus (HCV) 5.7%. Male sex, diabetes, HBV, and HCV were associated with significant fibrosis/cirrhosis, while ART for >5 years was associated with reduced risk. Conclusion: The chronic hepatitis viruses are associated with significant liver fibrosis/cirrhosis in PLWH in Nigeria, highlighting the importance of viral hepatitis awareness, screening, and treatment in HIV programs to reduce the risk of liver disease. Plain Language Summary: Hepatitis B and C infection and liver disease in people with HIV infection in Nigeria People living with human immunodeficiency virus (HIV) infection who have hepatitis B or C infection have a higher chance of developing advanced liver disease than those who do not have either of the hepatitis infections. This finding highlights the importance of awareness, screening, and treatment of the hepatitis viruses in HIV programs in order to reduce the risk of liver disease in this population.

Original languageEnglish (US)
JournalJournal of the International Association of Providers of AIDS Care
Volume23
DOIs
StatePublished - Jan 1 2024

Funding

We thank Professor Folasade Ogunsola for her contributions to this work. The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was funded by the Division of Cancer Prevention, National Cancer Institute, grant no.: NIH/NCI U54CA221205 (PI Robert Murphy, Lifang Hou).

Keywords

  • HBV
  • HCV
  • HIV
  • Nigeria
  • fibroscan
  • liver disease
  • liver fibrosis

ASJC Scopus subject areas

  • Immunology
  • Dermatology
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Hepatitis B and C Virus Co-Infection and Their Association With Liver Disease in Persons With HIV in Nigeria'. Together they form a unique fingerprint.

Cite this